Scheme
ITI Pharma and Healthcare Fund
Holds 37 companies worth ₹264 Cr in Sept 2026.
Fund house
ITIThe fund house that runs this scheme.AUM
₹266 CrITI Pharma and Healthcare Fund's AUM at the end of 30 Sept 2026, as AMFI reports it. Down 3.7% on Aug 2026, ₹276 Cr.Largest holding
Sun Pharmaceutical Ind LtdSun Pharmaceutical Ind Ltd is 12.0% of this scheme's NAV.Fund manager
Nilay DalalRuns it since 8 May 2026, as the fund house dates it. With Animesh Singh (fund manager).
Overview(7 Oct 2026)
Fund managers2
- Nilay DalalFund manager · May 2026 · 14y · MBA
- Animesh SinghFund manager · May 2026 · 23y · CFA PGDM
- Dhimant ShahDec 2022 – May 2026
- Rajesh BhatiaJun 2024 – Apr 2026
- Rohan KordeNov 2021 – Apr 2026
Key facts
- Benchmark
- Nifty Healthcare Total Return Index
- Risk
- Very High
- Expense
- Regular 2.59% · Direct 0.89%
- Exit load
- 0.5% within 3 months
- Started
- 8 Nov 2021
- Minimum
- ₹5,000
Source.Its Scheme Summary Document as of 7 Oct 2026 at AMFI.
What changed(11 changes)
Aug 2026
1 change
- Expense ratio30 AugRegular 2.69% → 2.63%Direct 0.98% → 0.92%
Jul 2026
1 change
- Expense ratio30 JulRegular 2.66% → 2.69%Direct 0.95% → 0.98%
Jun 2026
1 change
- Expense ratio29 JunRegular 2.38% → 2.66%Direct 0.68% → 0.95%
Source.Its filings at NSE, since Jul 2025.
Fund managers over time(Nov 2021 – now)
MainCoSlice20222023202420252026
Costs(Jul 2025 – Oct 2026)
Direct plan, 30 Aug 2026
0.92%
Regular plan 2.63% · Exit load 0.5% within 3 months
Objective and risk(7 Oct 2026)
Objective
The investment objective of the scheme is to seek to generate long term capital appreciation through investing in equity and equity related securities of companies engaged in Pharma and Healthcare. However, there can be no assurance that the investment objective of the scheme would be achieved.
Risk, type and benchmark
- Riskometer
- Very High
- At launch
- Very High
- Type
- An open ended Equity scheme investing in Pharma and Healthcare
- Benchmark
- Nifty Healthcare Total Return Index
Asset allocation it may hold% of NAV
- Equity, Units issued by REITs & Equity related instruments of companies engaged in pharma and healthcareAllowed80–100%
- Equity, Units issued by REITs and Equity related securities of other CompaniesAllowed0–20%
- Listed Preference SharesAllowed0–10%Holds99.3%
- Debt and Money Market InstrumentsAllowed0–20%Holds0.7%
- Units issued by InvITsAllowed0–10%Holds0.0%
Holds in Sept 2026.99.3% equity · 0.7% debt and cash
How to invest(7 Oct 2026)
Buying
- To start
- ₹5,000, then in multiples of ₹1
- To add
- ₹1,000, then in multiples of ₹1
- Systematic
- SIP-Daily/Weekly/Monthly, STP- Daily/Weekly/Monthly/Quarterly, SWP- Monthly/ Quarterly
- Dates
- SIP-Daily (Every Business Day), Weekly (Any Day from Monday to Friday),Monthly (Every Business Day), STP- Daily (Every Business Day), Weekly (Any Day from Monday to Friday),Quarterly (1st or 7th or 14th or 21st or 28th of last month of every quarter), Monthly (1,7,14,21 or 28th of the month), SWP-Monthly and Quarterly (1,7,14,21 or 28th of every month/month of every quarter)
- Minimum
- SIP-Daily: Rs. 500/-/ Weekly and Monthly:Rs. 500/- or Rs. 1000/-, STP- Rs. 500/-, SWP- Rs. 1000/-, then sIP-1, STP-1, SWP-1
- Instalments
- SIP-Daily- 30 ; Weekly/Monthly -12 or 6, STP-Daily-30; Weekly /Monthly/Quarterly-2, SWP- Monthly/Quarterly-2
- Most
- Nil
Selling and switching
- To redeem
- ₹1,000
- Switch minimum
- ₹5,000
- Switch multiples
- ₹1
Scheme details(7 Oct 2026)
What it is
- Category
- Sectoral/Thematic Funds
- Offer
- 18 Oct 2021 to 1 Nov 2021
- Started
- 8 Nov 2021
- Reopened
- 11 Nov 2021
- Plans
- Regular Plan- Growth Option · Regular Plan- Income Distribution cum Capital Withdrawal (IDCW) Option (with Payout of IDCW option) · Regular Plan- Income Distribution cum Capital Withdrawal (IDCW) Option (with Reinvestment of IDCW option) · Direct Plan- Growth Option · Direct Plan- Income Distribution cum Capital Withdrawal (IDCW) Option (with Payout of IDCW option) · Direct Plan- Income Distribution cum Capital Withdrawal (IDCW) Option (with Reinvestment of IDCW option)
- Face value
- Rs.10/- each
- Listed
- No
How it is run
- Swing pricing
- No
- Side-pocketing
- No
- Custodian
- Deutsche Bank A.G.
- Auditor
- S. R. Batliboi & Co. LLP
- Registrar
- KFin Technologies Limited
- SEBI code
- ITIM/O/E/SEC/21/09/0014